Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:25:13.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new information about a study on atopic dermatitis, specifically mentioning the EudraCT number and a revision update. However, significant details about the study's objectives and criteria have been removed.
    Difference
    7%
    Check dated 2025-04-16T20:37:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 9, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.4%
    Check dated 2025-04-09T14:53:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision version (v2.14.3) and a new date for the results first posted, changing from January 9, 2025, to March 25, 2025.
    Difference
    0.3%
    Check dated 2025-04-02T00:19:55.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T23:15:53.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T16:48:12.000Z thumbnail image

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.